Kaoru Irisa

408 total citations
16 papers, 333 citations indexed

About

Kaoru Irisa is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Kaoru Irisa has authored 16 papers receiving a total of 333 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 8 papers in Pulmonary and Respiratory Medicine and 3 papers in Molecular Biology. Recurrent topics in Kaoru Irisa's work include Lung Cancer Treatments and Mutations (8 papers), Lung Cancer Research Studies (6 papers) and Lung Cancer Diagnosis and Treatment (3 papers). Kaoru Irisa is often cited by papers focused on Lung Cancer Treatments and Mutations (8 papers), Lung Cancer Research Studies (6 papers) and Lung Cancer Diagnosis and Treatment (3 papers). Kaoru Irisa collaborates with scholars based in Japan, Italy and United States. Kaoru Irisa's co-authors include Katsuhiro Masago, Michiaki Mishima, Tadashi Mio, Shiro Fujita, Yuichi Sakamori, Yosuke Togashi, Young Hak Kim, Ken‐ichi Inui, Tomohiro Terada and Masahide Fukudo and has published in prestigious journals such as Cancer Science, Journal of Thoracic Oncology and Cancer Chemotherapy and Pharmacology.

In The Last Decade

Kaoru Irisa

16 papers receiving 331 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kaoru Irisa Japan 9 236 214 76 48 24 16 333
Guilherme Harada Brazil 11 161 0.7× 155 0.7× 90 1.2× 66 1.4× 31 1.3× 40 317
Yoshiro Nakahara Japan 12 255 1.1× 282 1.3× 55 0.7× 54 1.1× 23 1.0× 42 414
Sabine Glaser Switzerland 5 211 0.9× 137 0.6× 104 1.4× 49 1.0× 52 2.2× 8 296
R. K. Ramanathan United States 11 103 0.4× 292 1.4× 73 1.0× 45 0.9× 35 1.5× 32 370
Chukwuemeka Ikpeazu United States 9 144 0.6× 189 0.9× 119 1.6× 65 1.4× 42 1.8× 23 356
Michela Lia Italy 9 249 1.1× 147 0.7× 112 1.5× 70 1.5× 33 1.4× 15 328
Susan E. Jorge Brazil 7 200 0.8× 137 0.6× 112 1.5× 51 1.1× 20 0.8× 22 303
Keita Uchino Japan 12 151 0.6× 215 1.0× 86 1.1× 39 0.8× 59 2.5× 40 357
Luigi Cerbone Italy 10 222 0.9× 125 0.6× 109 1.4× 93 1.9× 24 1.0× 40 308
You Lu China 9 298 1.3× 251 1.2× 59 0.8× 46 1.0× 34 1.4× 22 338

Countries citing papers authored by Kaoru Irisa

Since Specialization
Citations

This map shows the geographic impact of Kaoru Irisa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kaoru Irisa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kaoru Irisa more than expected).

Fields of papers citing papers by Kaoru Irisa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kaoru Irisa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kaoru Irisa. The network helps show where Kaoru Irisa may publish in the future.

Co-authorship network of co-authors of Kaoru Irisa

This figure shows the co-authorship network connecting the top 25 collaborators of Kaoru Irisa. A scholar is included among the top collaborators of Kaoru Irisa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kaoru Irisa. Kaoru Irisa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Irisa, Kaoru, et al.. (2022). Hospital Management and Public Health Role of National Hospitals after Transformation into Independent Administrative Agencies. Healthcare. 10(10). 2084–2084. 3 indexed citations
2.
Masago, Katsuhiro, Yosuke Togashi, Masahide Fukudo, et al.. (2011). Plasma and Pleural Fluid Pharmacokinetics of Erlotinib and its Active Metabolite OSI-420 in Patients With Non–Small-Cell Lung Cancer With Pleural Effusion. Clinical Lung Cancer. 12(5). 307–312. 20 indexed citations
3.
Masago, Katsuhiro, Shiro Fujita, Yosuke Togashi, et al.. (2011). Association between brain natriuretic peptide and distant metastases in advanced non-small cell lung cancer patients. Oncology Letters. 2(2). 253–256. 3 indexed citations
4.
Togashi, Yosuke, Katsuhiro Masago, Masahide Fukudo, et al.. (2010). Pharmacokinetics of Erlotinib and Its Active Metabolite OSI-420 in Patients with Non-small Cell Lung Cancer and Chronic Renal Failure Who Are Undergoing Hemodialysis. Journal of Thoracic Oncology. 5(5). 601–605. 42 indexed citations
5.
6.
Kim, Young Hak, Tadashi Mio, Katsuhiro Masago, et al.. (2010). Retrospective analysis of Japanese patients with relapse or refractory small-cell lung cancer treated with amrubicin hydrochloride. Oncology Letters. 1(3). 569–572. 3 indexed citations
7.
Masago, Katsuhiro, Yosuke Togashi, Masahide Fukudo, et al.. (2010). Good Clinical Response to Erlotinib in a Non-Small Cell Lung Cancer Patient Harboring Multiple Brain Metastases and a Double Active Somatic Epidermal Growth Factor Gene Mutation. Case Reports in Oncology. 3(2). 98–105. 10 indexed citations
8.
Masago, Katsuhiro, Shiro Fujita, Yosuke Togashi, et al.. (2010). Clinical Significance of Pretreatment C-Reactive Protein in Patients with Advanced Nonsquamous, Non-Small Cell Lung Cancer Who Received Gefitinib. Oncology. 79(5-6). 355–362. 19 indexed citations
9.
Fukuhara, Akiko, Katsuhiro Masago, Masashi Neo, et al.. (2010). Outcome of Surgical Treatment for Metastatic Vertebra Bone Tumor in Advanced Lung Cancer. Case Reports in Oncology. 3(1). 63–71. 13 indexed citations
10.
Masago, Katsuhiro, Shiro Fujita, Young Hak Kim, et al.. (2010). Phase I study of the combination of nedaplatin and gemcitabine in previously untreated advanced squamous cell lung cancer. Cancer Chemotherapy and Pharmacology. 67(2). 325–330. 6 indexed citations
11.
Masago, Katsuhiro, Shiro Fujita, Tadashi Mio, et al.. (2010). Clinical significance of the ratio between the alpha 2 plasmin inhibitor–plasmin complex and the thrombin–antithrombin complex in advanced non-small cell lung cancer. Medical Oncology. 28(1). 351–356. 16 indexed citations
12.
Masago, Katsuhiro, Akiko Fukuhara, Isao Ito, et al.. (2010). Infectious background of febrile advanced lung cancer patients who received chemotherapy. Oncology Letters. 1(5). 849–853. 4 indexed citations
13.
Masago, Katsuhiro, Shiro Fujita, Kaoru Irisa, et al.. (2010). Good Clinical Response to Gefitinib in a Non-small Cell Lung Cancer Patient Harboring a Rare Somatic Epidermal Growth Factor Gene Point Mutation; Codon 768 AGC > ATC in Exon 20 (S768I). Japanese Journal of Clinical Oncology. 40(11). 1105–1109. 42 indexed citations
14.
Togashi, Yosuke, Katsuhiro Masago, Masahide Fukudo, et al.. (2010). Cerebrospinal Fluid Concentration of Erlotinib and its Active Metabolite OSI-420 in Patients with Central Nervous System Metastases of Non-small Cell Lung Cancer. Journal of Thoracic Oncology. 5(7). 950–955. 107 indexed citations
15.
Togashi, Yosuke, Young Hak Kim, Ryo Miyahara, et al.. (2010). Octreotide, a Somatostatin Analogue, in the Treatment of Chylothorax Associated with Idiopathic Fibrosing Mediastinitis. The Tohoku Journal of Experimental Medicine. 222(1). 51–53. 5 indexed citations
16.
Masago, Katsuhiro, Shiro Fujita, Yukimasa Hatachi, et al.. (2009). Effect of vascular endothelial growth factor polymorphisms on survival in advanced‐stage non‐small‐cell lung cancer. Cancer Science. 100(10). 1917–1922. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Guilherme Harada Breakdown of academic impact, for papers by Yoshiro Nakahara Breakdown of academic impact, for papers by Sabine Glaser Breakdown of academic impact, for papers by R. K. Ramanathan Breakdown of academic impact, for papers by Chukwuemeka Ikpeazu Breakdown of academic impact, for papers by Michela Lia Breakdown of academic impact, for papers by Susan E. Jorge Breakdown of academic impact, for papers by Keita Uchino Breakdown of academic impact, for papers by Luigi Cerbone Breakdown of academic impact, for papers by You Lu
Rankless by CCL
2026